You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Karyopharm

Showing 51 - 74 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)

Completed
Has Results
  • Coronavirus Infection
  • Los Angeles, California
  • +32 more
Oct 27, 2021

Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

Completed
Has Results
  • Dedifferentiated Liposarcoma
  • Los Angeles, California
  • +70 more
Jan 5, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Prostate Cancer Trial in Houston (Selinexor)

Terminated
Has Results
  • Prostate Cancer
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 7, 2021

Healthy Trial in Melbourne (Verdinexor, Placebo)

Terminated
Has Results
  • Healthy
  • Melbourne, Victoria, Australia
    Nucleus Network
Mar 18, 2021

Squamous Cell Carcinoma Trial in Canada, United States (Selinexor (KPT-330))

Terminated
Has Results
  • Squamous Cell Carcinoma
  • Selinexor (KPT-330)
  • Aurora, Colorado
  • +17 more
Nov 6, 2020

Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Australia, Singapore (Selinexor)

Terminated
Has Results
  • Peripheral T-cell Lymphoma (PTCL)
  • Cutaneous T-cell Lymphoma (CTCL)
  • Concord, New South Wales, Australia
  • +4 more
Sep 8, 2020

Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)

Completed
  • Peripheral T-cell Lymphoma
  • Singapore, Singapore
    National Cancer Centre Singapore
Apr 27, 2021

Richter's Transformation Trial in Worldwide (selinexor)

Terminated
Has Results
  • Richter's Transformation
  • Tucson, Arizona
  • +16 more
Sep 8, 2020

Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 7, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
Has Results
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
Has Results
  • Hematological Malignancies
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
Has Results
  • Ovarian Carcinoma
  • +2 more
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Solid Tumor Trial in Canada, Denmark, United States (Selinexor, Acetaminophen)

Completed
Has Results
  • Solid Tumor
  • Tampa, Florida
  • +5 more
Apr 6, 2021

Thymoma, Advanced Thymic Epithelial Tumour Trial in Copenhagen, Lyon, Paris (Selinexor)

Unknown status
  • Thymoma
  • Advanced Thymic Epithelial Tumour
  • Copenhagen, Denmark
  • +3 more
Mar 9, 2018

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +7 more
  • mitoxantrone hydrochloride
  • +5 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Apr 2, 2018

Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Columbus (decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Dec 6, 2017

Myeloma Multiple Trial in Birmingham, London, Southampton (Cyclophosphamide, Lenalidomide, Pembrolizumab)

Withdrawn
  • Myeloma Multiple
  • Birmingham, United Kingdom
  • +3 more
Aug 22, 2017

Recurrent Small Cell Lung Carcinoma Trial in Columbus (Selinexor, Laboratory Biomarker Analysis, Pharmacological Study)

Terminated
Has Results
  • Recurrent Small Cell Lung Carcinoma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 12, 2016

Myelodysplastic Syndrome Trial (Selinexor)

Withdrawn
  • Myelodysplastic Syndrome
  • (no location specified)
Mar 28, 2017

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma Trial (Docetaxel, Laboratory Biomarker Analysis,

Withdrawn
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma
  • (no location specified)
Oct 28, 2015

Rectal Tumors Trial in Ramat Gan (standard dose pelvic radiation therapy, standard dose capecitabine, dose-escalated selinexor

Unknown status
  • Rectal Neoplasms
  • standard dose pelvic radiation therapy
  • +2 more
  • Ramat Gan, Israel
    Sheba Medical Center
Sep 2, 2015

Diabetic Foot Ulcers Trial in Auckland (Selinexor, Standard-of-Care, Vehicle Gel)

Withdrawn
  • Diabetic Foot Ulcers
  • Auckland, New Zealand
    South Pacific Clinical Trials
Mar 23, 2016

Multiple Myeloma Trial (Selinexor, Lenalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Sep 1, 2015